Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Biological age & clocks
Video summary

Podcast: Dr. Barzilai on aging clocks, hype and longevity medicine

In this podcast description, Dr. Kara Fitzgerald and longevity physician Dr. David Barzilai discuss biological age testing such as DunedinPACE, separating longevity science from hype, and where longevity medicine may be headed. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The description says the episode discusses biological age testing, including DunedinPACE and other aging clocks, and why these tools can be useful without telling the whole story. [1]

  2. The description lists separating promising longevity science from hype and thinking critically about supplements and longevity hacks as topics. [1]

  3. The description says individualized diet, exercise, sleep and other foundational interventions still come first, and that AI could change personalized longevity medicine. [1]

The source at a glance

Study type / format
Video description of a podcast episode
Population / context
A podcast conversation between Dr. Kara Fitzgerald and longevity physician Dr. David Barzilai, as described.
Summary based on
Creator description
Original publication
September 25, 2026

Aging clocks in the described conversation

The description says the two discuss the evolution of biological age testing, naming DunedinPACE and other aging clocks. According to the description, they explain why these tools can give useful information without telling the whole story. The description also lists as a learning point what biological age and aging clocks can and cannot tell us. No measured results from any clock are reported in the description.

Supporting source [1]

Science versus hype and the fundamentals

The description frames the episode as separating promising science from hype. It says the conversation covers how to think critically about the growing number of supplements and longevity hacks, and why slowing the rate of aging may matter more than chasing a biological age number. It also states that individualized diet, exercise, sleep and other foundational interventions still come first. These are described topics of the conversation, not findings from a study.

Supporting source [1]

AI, clinicians and the described outlook

The description says the episode explores how artificial intelligence and emerging technologies could transform personalized medicine and help clinicians better identify which interventions may benefit an individual. It also mentions how clinicians can evaluate emerging longevity therapies without getting ahead of the evidence, and where longevity and geroscience may be headed next. These are framed as possibilities and discussion points, not demonstrated outcomes.

Supporting source [1]

How to interpret this

This is based only on the video description. The video and transcript were not reviewed, so the actual discussion, any evidence cited and any results are unknown. The description reports no study design, sample or measured outcomes.

Based on the creator’s description; the full video and transcript were not analyzed.

Source & supporting passages

[1]
What Actually Slows Aging? The Science vs Hype | Dr David Barzilai

Dr. Kara Fitzgerald FxMed, Longevity & Epigenetics · youtube.com · September 25, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    including DunedinPACE and other aging clocks
  2. Finding 2 ↑

    distinguish promising longevity science from hype
  3. Finding 3 ↑

    individualized diet, exercise, sleep, and other foundational

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…